Next-generation Drosophila protein interactome map and its functional implications.

affinity purification interactome interologs modifiers notch pathway protein interaction proteome

Journal

Developmental cell
ISSN: 1878-1551
Titre abrégé: Dev Cell
Pays: United States
ID NLM: 101120028

Informations de publication

Date de publication:
27 Jun 2024
Historique:
received: 18 05 2023
revised: 27 01 2024
accepted: 05 06 2024
medline: 30 6 2024
pubmed: 30 6 2024
entrez: 29 6 2024
Statut: aheadofprint

Résumé

We describe a next-generation Drosophila protein interaction map-"DPIM2"-established from affinity purification-mass spectrometry of 5,805 baits, covering the largest fraction of the Drosophila proteome. The network contains 32,668 interactions among 3,644 proteins, organized into 632 clusters representing putative functional modules. Our analysis expands the pool of known protein interactions in Drosophila, provides annotation for poorly studied genes, and postulates previously undescribed protein interaction relationships. The predictive power and functional relevance of this network are probed through the lens of the Notch signaling pathway, and we find that newly identified members of complexes that include known Notch modifiers can also modulate Notch signaling. DPIM2 allows direct comparisons with a recently published human protein interaction network, defining the existence of functional interactions conserved across species. Thus, DPIM2 defines a valuable resource for predicting protein co-complex memberships and functional associations as well as generates functional hypotheses regarding specific protein interactions.

Identifiants

pubmed: 38944040
pii: S1534-5807(24)00380-0
doi: 10.1016/j.devcel.2024.06.002
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests The authors declare no competing interests.

Auteurs

Guruharsha Bhat (G)

Department of Cell Biology, Harvard Medical School, Boston, MA, USA; Biogen, 225 Binney St, Cambridge, MA 02142, USA.

Kejie Li (K)

Biogen, 225 Binney St, Cambridge, MA 02142, USA; Triveni Bio, Watertown, MA, USA.

George Locke (G)

Biogen, 225 Binney St, Cambridge, MA 02142, USA; Senda Biosciences, Cambridge, MA, USA.

Marina Theodorou (M)

Department of Cell Biology, Harvard Medical School, Boston, MA, USA; Biogen, 225 Binney St, Cambridge, MA 02142, USA; Nereid Therpaeutics, Boston, MA 02210, USA.

Krishna Kilambi (K)

Biogen, 225 Binney St, Cambridge, MA 02142, USA; Pfizer, Cambridge, MA, USA.

Kazuya Hori (K)

Department of Cell Biology, Harvard Medical School, Boston, MA, USA; University of Fukui, Fukui, Japan.

Diana Ho (D)

Department of Cell Biology, Harvard Medical School, Boston, MA, USA.

Robert Obar (R)

Department of Cell Biology, Harvard Medical School, Boston, MA, USA.

Leah Williams (L)

Department of Cell Biology, Harvard Medical School, Boston, MA, USA.

Hannah Parzen (H)

Department of Cell Biology, Harvard Medical School, Boston, MA, USA.

Noah Dephoure (N)

Department of Cell Biology, Harvard Medical School, Boston, MA, USA.

Craig Braun (C)

Department of Cell Biology, Harvard Medical School, Boston, MA, USA.

Marc Muskavitch (M)

Department of Cell Biology, Harvard Medical School, Boston, MA, USA.

Susan E Celniker (SE)

Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, Berkeley, CA, USA.

Steven Gygi (S)

Department of Cell Biology, Harvard Medical School, Boston, MA, USA.

Spyros Artavanis-Tsakonas (S)

Department of Cell Biology, Harvard Medical School, Boston, MA, USA. Electronic address: artavanis@hms.harvard.edu.

Classifications MeSH